193 related articles for article (PubMed ID: 27085427)
1. Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds.
Tanaka A; Jabbour RJ; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Imaging; 2016 Dec; 9(12):1469-1470. PubMed ID: 27085427
[No Abstract] [Full Text] [Related]
2. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
[No Abstract] [Full Text] [Related]
3. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
4. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
Sato T; Richardt G; Abdel-Wahab M
Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
[No Abstract] [Full Text] [Related]
5. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
[No Abstract] [Full Text] [Related]
6. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
Granata F; Moscarella E; Varricchio A
Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
[No Abstract] [Full Text] [Related]
7. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
[No Abstract] [Full Text] [Related]
8. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
9. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
[No Abstract] [Full Text] [Related]
10. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
[No Abstract] [Full Text] [Related]
11. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
[No Abstract] [Full Text] [Related]
12. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
Karanasos A; Garcia-Garcia HM; van Geuns RJ; Regar E
JACC Cardiovasc Interv; 2015 Mar; 8(3):e53-e54. PubMed ID: 25790767
[No Abstract] [Full Text] [Related]
13. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
14. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
Lee WC; Fang HY; Fang CY
Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
[No Abstract] [Full Text] [Related]
15. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
[No Abstract] [Full Text] [Related]
16. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
Longo G; Granata F; Capodanno D; Ohno Y; Tamburino CI; Capranzano P; La Manna A; Francaviglia B; Gargiulo G; Tamburino C
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1150-61. PubMed ID: 25573598
[TBL] [Abstract][Full Text] [Related]
17. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
[No Abstract] [Full Text] [Related]
18. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
Foin N; Lee R; Wong P; Low AF
EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
[No Abstract] [Full Text] [Related]
19. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds.
Gori T; Schulz E; Münzel T
JACC Cardiovasc Interv; 2014 Oct; 7(10):1194-5. PubMed ID: 25240537
[No Abstract] [Full Text] [Related]
20. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
